Login
$COLL
$25.43 +$0.11 (0.43%) Live

$COLL SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
16 Nov 2026 SCHEDULE 13G/A
10 Nov 2026 SCHEDULE 13G/A
10 Nov 2026 SCHEDULE 13G
05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

– Generated Record Quarterly Net Revenues of $216.3 Million, Up 3% Year-over-Year –

30 Oct 2026 SCHEDULE 13G/A
29 Oct 2026 SCHEDULE 13G/A
19 Oct 2026 8-K: Termination of a Material Definitive Agreement

As previously disclosed, Collegium Pharmaceutical, Inc. (the “Company”) is party to a License Agreement (U.S.), dated as of January 13, 2015, with Grünenthal GmbH (“Grünenthal”) (as amended, the “Grünenthal License”) which the Company as...

08 Oct 2026 SCHEDULE 13G/A
30 Sep 2026 144
24 Aug 2026 SCHEDULE 13G
14 Aug 2026 SCHEDULE 13G
13 Aug 2026 8-K: Other Events

On August 12, 2026, Collegium Pharmaceutical, Inc. (“Collegium” or the “Company”) announced the execution of an accelerated share repurchase agreement (the “ASR Agreement”) with Jefferies LLC to repurchase $50 million of the Company’s co...

06 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

– Completed Acquisition of AZSTARYS®, Strengthening ADHD Portfolio and Extending Long-Term Revenue Outlook –

05 Aug 2026 SCHEDULE 13G
31 Jul 2026 SCHEDULE 13G
17 Jul 2026 144
15 Jul 2026 144

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support